Last reviewed · How we verify
oxytocin treatment
At a glance
| Generic name | oxytocin treatment |
|---|---|
| Sponsor | University of Electronic Science and Technology of China |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Hypotension
- Nausea
- Headache
- Vomiting
Key clinical trials
- 3-hour Versus 12-hour Double-balloon Catheter for Labor Induction: a Randomized Trial (NA)
- Oxytocin to Treat PTSD (PHASE2)
- Intra-Umbilical Vein Oxytocin Injection as an Adjunct to Active Management of the Third Stage of Labour (NA)
- Comparison of Two Different Doses of Phenylephrine on Oxytocin Hemodynamic Effect (PHASE4)
- Efficacy of Intravenous Oxytocin to Speed Recovery After THA (PHASE2)
- Oxytocin's Effects on Emotional Processing and Its Acting Routes (NA)
- Differences in Mechanistic Measures (Oxytocin and Cortisol) of Therapeutic Alliance Between A Talk-Based Therapy and Soft-Tissue Mobilization in Individuals With Chronic Spinal Pain (NA)
- Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- oxytocin treatment CI brief — competitive landscape report
- oxytocin treatment updates RSS · CI watch RSS
- University of Electronic Science and Technology of China portfolio CI